2026-27 Flu Outlook: After a 25-Year Record Season, Early Signals

For health system and health IT leaders, the 2026–27 flu season is a forecasting problem as much as a clinical one. CDC data show the 2025–26 "superflu winter" drove influenza-like illness visits to their highest level in more than 25 years, and that demand spike tested syndromic surveillance, ED throughput and bed-capacity analytics. With Australia's 2026 season running moderate and vaccines re-targeted to the subclade K strain, the next few months will reveal whether forecasting models and early-warning data streams are better calibrated this time.

The 2026–2027 Northern Hemisphere influenza season is taking shape in the shadow of a historically severe predecessor. According to U.S. Centers for Disease Control and Prevention data cited in syndicated NBC reporting published September 9, 2026, the 2025–2026 "superflu winter" pushed doctors' visits for influenza-like illness to their highest level in more than 25 years, ranking among the worst flu seasons in decades. With respiratory viruses already beginning to ramp up across the United States before summer has officially ended — and seasonal influenza activity still low relative to COVID-19 — public health experts are urging early preparation while warning that meaningful severity forecasts remain weeks away.

“

With Australia's 2026 season running moderate and vaccines re-targeted to the subclade K strain, the next few months will reveal whether forecasting models and early-warning data streams are better calibrated this time.

The central tension in the current outlook is between reassuring early signals and the virus's well-documented capacity for surprise. "The only thing that's predictable about influenza is it's unpredictable," Dr. Daniel Jernigan, a former CDC director and contributing scholar at the Johns Hopkins Bloomberg School of Public Health, told TODAY.com. That unpredictability frames how forecasters approach the season. "Predicting the severity of flu seasons is a delicate art," said Dr. Albert Ko, professor of epidemiology at Yale School of Public Health. Scientists blend statistical forecasting models with surveillance data from the Southern Hemisphere, whose winter arrives months earlier and whose season is widely treated as a leading indicator for North America.

Australia, the most closely watched harbinger, is currently producing a cautiously encouraging signal. Ko notes that Australia's 2026 flu season has been moderate so far and materially milder than 2025, the country's busiest and deadliest in decades. Australian case counts are surging later than usual but remain nowhere near the 2025 peak. That pattern — a late-starting, lower-amplitude Southern Hemisphere wave — has historically been associated with reduced Northern Hemisphere pressure, but experts are careful not to over-read it. The same mutational drift that forced an updated vaccine composition this year could re-emerge during the fall.

On the countermeasure side, the strain-selection cycle has already moved. Earlier in 2026, scientists updated the 2026–2027 influenza vaccines to protect against the subclade K strain, a composition change designed to improve antigenic match against circulating lineages. The CDC continues to project that U.S. flu activity will peak between December and February, though timing and severity vary from year to year. Vaccine rollout timing relative to any early-season surge, and the durability of match as the virus evolves, will be the two operational variables that determine whether health systems face another capacity-straining winter.